Exponent CEO Trims Equity Stake Amid Executive Leadership Transition

Catherine Corrigan, President and CEO of Exponent (NASDAQ: EXPO), has reduced her direct equity position through the sale of 7,821 shares. The transactions, conducted via open-market sales between March 16 and April 15, 2026, were executed at a weighted average price of $67.59 per share. The sale followed the exercise of 8,831 options and represents roughly 6.97% of Corrigan's direct holdings. Despite the divestment, the CEO retains over 104,000 shares, maintaining a significant vested interest in the global science and engineering consulting firm. This equity activity occurs alongside a strategic leadership transition. Effective May 1, John Pye will assume a newly created role as president, while Eric Anderson is set to take over as Chief Financial Officer. These changes come as the stock trades approximately 15% below its 52-week high, reflecting some market uncertainty regarding the transition. Exponent's fundamental performance remains stable, though growth has been modest. For fiscal year 2025, the company reported revenues of $536.8 million, a 3.5% increase, and net income of $106 million, representing $2.07 per diluted share. Looking ahead to 2026, management has provided guidance for high single-digit net revenue growth. Additionally, the board has increased the quarterly dividend to $0.31 per share, signaling confidence in the company's cash flow and long-term stability.